Moreno v. United States

CourtDistrict Court, E.D. Texas
DecidedMarch 20, 2020
Docket1:19-cv-00156
StatusUnknown

This text of Moreno v. United States (Moreno v. United States) is published on Counsel Stack Legal Research, covering District Court, E.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Moreno v. United States, (E.D. Tex. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF TEXAS BEAUMONT DIVISION ENRIQUE MORENO IV § VS. § CIVIL ACTION NO. 1:19cv156 UNITED STATES OF AMERICA § MEMORANDUM OPINION AND ORDER Enrique Moreno IV, as administrator of the Estate of Moreno III, proceeding pro se, brings this lawsuit pursuant to the Federal Torts Claims Act, 28 U.S.C. § 2671, et. seq. (the "FTCA"), against the United States of America. The defendant has filed a motion to dismiss (doc. no. 5). Plaintiff has filed a reply to the motion. The motion is therefore ripe for consideration. Factual Allegations Plaintiff alleges that on November 16, 2011, Enrique Moreno III was seen at Texas Oncology where he tested positive for the Hepatitis C virus (“HCV”). However, the Bureau of Prisons (“BOP”) did not make note of this diagnosis until an administrative note dated October 8, 2012. Plaintiff states HCV is an infection spread through contaminated blood that causes liver inflamation which can lead to serious liver damage. He states chronic HCV is usually curable with oral medications taken every day for two to six months. Chronic HCV becomes apparent in symptoms that may include fluid build up in the abdomen, leg swelling, weight loss, confusion/drowsiness/slurred speech, spider angiomas, itchy skin, dark-colored urine, poor appetite, fatigue, and easy bruising and bleeding. Plaintiff alleges Mr. Moreno underwent serology testing on September 20, 2012, which again showed he was positive for the HCV antibody, specifically Type IB. On July 5, 2013, he was seen at Baptist Beaumont Hospital for an abdomen ultrasound, where it was noted he was suffering from liver disease and HCV. Plaintiff states that as part of its evaluation and management of HCV infections amongst the inmate population, the BOP assigns each HCV patient with an aspartate aminotransferase to platelet ratio index (“APRI”) score. In June, 2014, the BOP issued guidance stating that HCV infection should be prioritized for treatment in scenarios involving advanced hepatic fibrosis/cirrhosis. According to these guidelines, in determining the degree of fibrosis, inmates should be prioritized for treatment if they have an APRI score greater than or equal to 1.0 or if their APRI score is between 0.7 and 1.0 and there are other findings suggestive of advanced fibrosis. While a liver biopsy was not required, results of a prior liver biopsy could be used to meet the advanced fibrosis criteria. In July, 2015, additional guidelines were issued stating that while all patients with chronic HCV infection could benefit from treatment, certain cases were at higher risk for complications or disease progression and therefore required more urgent consideration for treatment. These guidelines state that cases of known cirrhosis or clinical findings consistent with cirrhosis constituted Priority Level 1, the highest priority for treatment. The guidelines stated that if a person was known to have cirrhosis, the APRI score was irrelevant and unnecessary. In October, 2016, the BOP issued guidelines providing that inmates were to be placed in Priority Level 1 if they had an APRI greater than or equal to 2.0, a Meavir or Batts/Ludwig stage 3 or 4 liver biopsy, or known or suspected cirrhosis. Similar guidance was issued in May, 2017, and January, 2018. Plaintiff alleges that at the very latest Mr. Moreno qualified for Priority Level 1 treatment by June, 2014, as he had been diagnosed with liver disease as recently as July 3, 2013. Plaintiff alleges that on February 9, 2014, Mr. Moreno sent a message to BOP chronic care nurse Brandi Whittington, a licenced vocational nurse, inquiring about his specific genotype and treatment options while incarcerated. The following day, Ms. Whittington responded by stating Mr. Moreno was Genotype I and that he would be put on the schedule to discuss possible HCV treatments. However, Ms. Whittington never discussed and/or presented treatment options to Mr. Moreno. 2 On July 14, 2014, Mr. Moreno reported to Health Services where he was seen by L. Lackey, a registered nurse. Mr. Moreno complained of a large and unexplained bump on the left side of his abdomen. Nurse Lackey noted Mr. Moreno’s small and narrow stools, the growing lump and associated pain, and his HCV history. Mr. Moreno was told he would be scheduled to see a provider for further evaluation. Plaintiff states Mr. Moreno reported to sick call on July 28, where he complained to Nurse Lackey and Lance Watson, another registered nurse, that he was worried about painful swelling on the left side of his abdomen and HCV. Nurse Watson noted that Mr. Moreno’s abdomen appeared swollen and noted his MCV diagnosis. It was noted that Mr. Moreno would be seen by a provider on July 31. On July 31, Nurse Practitioner S. Henderson noted that Mr. Moreno complained of a left abdominal protrusion. NP Henderson observed Mr. Moreno’s history of cirrhosis and noted that radiology of the abdomen was ordered for August 8. That same date, Mr. Moreno sent Ms. Whittington a message requesting his APRI scores. Ms. Whittington responded that Mr. Moreno’s APRI score was 0.785 on May 6, 2014, and that APRI scores were recalculated annually. Plaintiff asserts that according to the June, 2014, Guidelines, Mr. Moreno should have already qualified for Priority Level 1treatment as he was known to have liver disease and cirrhosis. On August 14, Mr. Moreno’s abdomen was x-rayed. The findings of Dr. Sandeep Amesur showed air in the gastrointestinal tract, but not gross evidence of obstruction or free air. Dr. Amesur’s report noted a 7 mm calcification over the left renal shadow and that left renal calculus would need consideration. On September 5, Mr. Moreno sent Ms. Whittington a message seeking his 2013 APRI score. She responded stating his 2013 score was 1.779, but that his 2014 score was substantially and unexplainably lower at 0.785. 3 On September 14, Mr. Moreno wrote Ms. Whittington seeking information about new HCV treatments as well as BOP’s treatment plan for him. He asked to be placed on the HCV waiting list for treatment. Ms. Whittington told him that as of 2011, there were at least four new treatments available for HCV. However, according to her interpretation of the guidelines, BOP would prioritize treatment for inmates with an APRI score above 1.0 with advanced hepatic fibrosis/cirrhosis. She stated Mr. Moreno did not meet this criteria because his APRI score on May 4, 2014 was 0.785. On October 20, Mr. Moreno sent a message to Health Services Administrator Emily Sonier, requesting attention from a doctor to determine to the cause of a grapefruit-sized lump on the left side of his abdomen. He said he was experiencing pain from the lump, which was growing, narrow and flat stools, and nerve-wracking anxiety over the potential cause of the lump. He stated that even though he had consistently requested medical attention, Health Services told him he should buy aspirin at the commissary and that he would be scheduled to see a doctor. However, this hadn’t happened. On October 16, Ms. Sonier responded, stating he was scheduled to see a doctor the next week and that he should watch call outs. On October 27, Dr. Issam Hamoush noted Mr. Moreno had a significant bulge on his left flank as compared with the right side. Dr. Hamoush asked that Mr. Moreno be seen by Gastroenterology for left abdomen distension, with narrow caliber stools tinged with blood. On October 31, Dr. Harmoush recommended that Mr. Moreno undergo a colonoscopy. On November 1, Mr. Moreno was seen by Dr. Bean, a gastroenterologist, who also recommended a colonoscopy. A nurse noted this in a clinical encounter administrative note. On November 3, in response to an order from Dr. Harmoush, Mr. Moreno underwent a complete blood count test.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Truman v. United States
26 F.3d 592 (Fifth Circuit, 1994)
Linkous v. USA
142 F.3d 271 (Fifth Circuit, 1998)
Chapa v. United States Department of Justice
339 F.3d 388 (Fifth Circuit, 2003)
Montez v. Department of the Navy
392 F.3d 147 (Fifth Circuit, 2004)
United States v. Orleans
425 U.S. 807 (Supreme Court, 1976)
Lane v. Pena
518 U.S. 187 (Supreme Court, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
Moreno v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/moreno-v-united-states-txed-2020.